2011 American Society of Breast Surgeons Annual Meeting

Breast Cancer

Caroline Helwick  / June 15 2011  / 2011 American Society of Breast Surgeons Annual Meeting

More Evidence Links Vitamin D Deficiency to Breast Cancer

Patients with breast cancer and deficient levels of 25-hydroxy-vitamin D are more likely to have aggressive tumor profiles and unfavorable prognostic markers than women with optimal levels of vitamin ...

Breast Cancer

Caroline Helwick  / June 15 2011  / 2011 American Society of Breast Surgeons Annual Meeting

Radiotherapy in DCIS: Recurrence Patterns Are Different

For women with ductal carcinoma in situ (DCIS), radiation therapy after excision is not a slam-dunk in terms of benefits, according to a study presented at the American Society of Breast Surgeons 12th...

Advertisement

Advertisement



Oct
23
Today In Oncology
IASLC 2017: Exercise Interventions in Advanced Lung Cancer Patients Led to Increased Functionality
IASLC 2017: Community Engagement Interventions May Reduce Disparities in Lung Cancer Outcomes Among Minorities
IASLC 2017: Non–Small Cell Lung Cancer Survival Rates Higher Among Patients Treated at Academic Centers
IASLC 2017: Poziotinib Yields High Response Rates in Patients With NSCLC With EGFR Exon 20 Insertion
Survival in Patients Treated With Adjuvant Chemoradiotherapy After Resection of Gastric Cancer
Sperm Banking for Adolescent Males With Newly Diagnosed Cancer
IASLC 2017: First-Line Pembrolizumab Increases Overall Survival vs Chemotherapy in Metastatic NSCLC With High Levels of PD-L1
FDA Approves CAR T-Cell Therapy to Treat Adults With Certain Types of Large B-Cell Lymphoma
View More 
Advertisement
Most Read Stories
Immunotherapy for Previously Treated Advanced Gastric Cancer
FDA Approves CAR T-Cell Therapy to Treat Adults With Certain Types of Large B-Cell Lymphoma
Combination Therapy for Patients With Advanced Unresectable Melanoma
Outcomes in Patients With Metastatic Lung Cancer Receiving PD-1/PD-L1 Inhibitors With Thoracic Radiotherapy
Survival in Patients Treated With Adjuvant Chemoradiotherapy After Resection of Gastric Cancer
IASLC 2017: CheckMate-032: Nivolumab Alone or With Ipilimumab in Recurrent SCLC With High Tumor Mutation Burden
IASLC 2017: Lorlatinib in ALK-Positive and ROS1-Positive Advanced Non–Small Cell Lung Cancer
Addition of EGFR Tyrosine Kinase Inhibitor to Chemotherapy in Resistant Non–Small Cell Lung Cancer
A Gleason 6 Tumor: Is It Cancer, and Should It Be Treated?
PI3K Inhibition in Relapsed or Refractory Indolent Lymphoma
© 2017 HSP News Service, L.L.C.